News & Views | Published:

Target watching with a beady eye

Nature Biotechnology volume 18, page 383 (2000) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Biotechnol. 18, 410–414 (2000).

  2. 2.

    et al. Cancer Res. 55, 6126–6232 (1995).

  3. 3.

    et al. Photochem. Photobiol. 66, 523–531 (1997).

  4. 4.

    et al. Biochim. Biophys. Acta 1402, 239–249 (1998).

  5. 5.

    et al. Nat. Biotechnol. 18, 321–325 (2000).

  6. 6.

    et al. Nat. Medicine. 6, 351–354 (2000).

  7. 7.

    et al. Radiology 178, 769–774 ( 1991).

  8. 8.

    et al. NMR Biomed. 13, 43–49 ( 2000).

  9. 9.

    et al. Cancer Res. 57, 3612–3619 (1997).

Download references

Author information

Affiliations

  1. Markus Rudin is head of the CTA/In Vivo Model Unit at Novartis Pharma AG, WSJ-386.2.02, CH-4002 Basel, Switzerland (markus-1.rudin@pharma.novartis.com ).

    • Markus Rudin

Authors

  1. Search for Markus Rudin in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/74432